Industrial production organization of vaccines “BRUVAC ®” and “BRUCON ®” against brucellosis of farm animals according to GMP standards
- August 16, 2024
Project number | AP15573700 |
Name of the project | Industrial production organization of vaccines “BRUVAC ®” and “BRUCON ®” against brucellosis of farm animals according to GMP standards |
Applicant | Research and Production Enterprise “Antigen” LLP |
Grantee | Research and Production Enterprise “Antigen” LLP |
Private Partner | No |
Implementation period | 2022-2024 |
Place of sale (city/region) | Almaty region |
Industry | Agro-industrial complex and processing of agricultural raw materials |
Implementation status | in the implementation |
Objective of the project | Industrial production of conjunctival vaccines against sheep and goat brucellosis “BRUVAC®” and against bovine brucellosis “BRUCON®”, in compliance with international GMP standards. |
Project Description | As a result of the project implementation, industrial production will be established, in accordance with international GMP standards, of the following veterinary drugs:
1. “BRUVAC®” live dry vaccine against sheep and goat brucellosis from Brucella melitensis Rev-1 strain, for conjunctival use. “BRUCON®” live dry vaccine against bovine brucellosis from Brucella abortus-19 strain for conjunctival use. The organization of industrial domestic production will provide high-quality, effective and economically beneficial vaccines, veterinary services and livestock farms of the Republic of Kazakhstan and neighboring countries, which will lead to an improvement in the epidemiological, epizootic and environmental situation for brucellosis in animals and humans. |
Website | www.antigen.kz |
List of products sold with prices | “BRUVAC® live dry vaccine against brucellosis of sheep and goats from the Brucella melitensis Rev-1 strain for conjunctival use” – 88.00 tenge. for 1 dose
“Vaccine” BRUCON® “live dry against brucellosis in cattle from the strain Brucella abortus-19 for conjunctival use” – 107.00 tenge. for 1 dose |
Project team (full name) | Akhmetsadykov Nurlan Nuroldinovich Ibrayev Bakhytzhan Niyazovich Abutalip Aspen Akhmetsadykova Shynar Nurlanovna Krykbayev Yerkin Aliibekovich |